All In MedTech

Device Trial Radar · NCT07932561

Expiratory Muscle Strength Training for People With Parkinson's Disease

Evaluation of Expiratory Muscle Strength Training in Parkinson's Disease - A Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Apr 8, 2024

Primary completion

Sep 30, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
Karolinska InstitutetAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Region Stockholm
First posted
Nov 12, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Post-Market Clinical Follow-up (PMCF) randomized controlled trial of a CE-marked device used in routine clinical practice. The goal of this study is to investigate whether Expiratory Muscle Strength Training (EMST) improves voice, speech, breathing, and swallowing function in people with Parkinson's disease. The research questions are: Does EMST improve voice, speech, breathing, and swallowing in people with Parkinson's disease, as measured by clinical tests, immediately after the training period and three months later? Does EMST lead to meaningful improvements in voice, speech, breathing, and swallowing problems as reported by people with Parkinson's disease immediately after the training period and three months later? Do the effects of EMST differ according to disease severity? Researchers will compare participants who receive EMST with participants in a passive control group to determine whether EMST improves voice, speech, breathing, and swallowing function. Participants will: Be randomly assigned to either an EMST group or a passive control group. Complete a structured EMST training program, if assigned to the intervention group. Attend study visits for assessments of voice, speech, breathing, and swallowing function. Undergo clinical tests and complete study-related evaluations throughout the study. Be monitored for any device-related or study-related adverse events.

Conditions

  • PARKINSON DISEASE (Disorder)

Interventions

  • Expiratory Muscle Strength Training (EMST)Device

    Expiratory Muscle Strength Training (EMST) will be performed using a CE-marked, calibrated handheld threshold device that provides a fixed expiratory resistance. Participants will complete 5 sets of 5 forceful expiratory breaths per day, 5 days per week, for 5 weeks. The training load will be individually calibrated and adjusted weekly based on each participant's performance to maintain an appropriate training intensity. The intervention is designed to strengthen expiratory and submental muscles involved in respiration, phonation, speech, and swallowing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sound Pressure Level/SPLTime frame: Assessment Time-points: (i) Baseline (two baseline measurements obtained 5 weeks apart), (ii) immediately post-intervention, and (iii) 3-month follow-up.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Speech and Language Therapy, Danderyd Hospital

    Stockholm, Stockholm County, Sweden · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.